Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,308
archived clinical trials in
Hepatitis

A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated:  3/30/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated: 3/30/2018
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated:  3/30/2018
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated: 3/30/2018
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated:  3/30/2018
Local Institution
mi
from
Buenos Aires,
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated: 3/30/2018
Local Institution
mi
from
Buenos Aires,
Click here to add this to my saved trials
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated:  3/30/2018
University of Florida
mi
from
Gainesville, FL
A Study of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus (HBV)-Infection
Evaluation of the Pharmacokinetics, Safety, Tolerability and Efficacy of Entecavir (ETV) in Pediatric Subjects With Chronic Hepatitis B Virus (HBV) Infection Who Are HBeAg-Positive
Status: Enrolling
Updated: 3/30/2018
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated:  4/2/2018
Ucsf Aids Crs (801)
mi
from
San Francisco, CA
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated: 4/2/2018
Ucsf Aids Crs (801)
mi
from
San Francisco, CA
Click here to add this to my saved trials
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated:  4/2/2018
7804 Weill Cornell Chelsea CRS
mi
from
New York, NY
12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF
Phase II Trial of Retreatment Strategies for Difficult-to-Treat Hepatitis C Virus (HCV)-Infected Individuals Who Have Failed Prior Direct Acting Antiviral (DAA)-Based Regimens
Status: Enrolling
Updated: 4/2/2018
7804 Weill Cornell Chelsea CRS
mi
from
New York, NY
Click here to add this to my saved trials
The Pathogenesis of Hepatitis C Virus Vertical Transmission
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated:  4/5/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
The Pathogenesis of Hepatitis C Virus Vertical Transmission
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated: 4/5/2018
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
The Pathogenesis of Hepatitis C Virus Vertical Transmission
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated:  4/5/2018
Cairo University
mi
from
Giza,
The Pathogenesis of Hepatitis C Virus Vertical Transmission
The Pathogenesis of Hepatitis C Virus Vertical Transmission
Status: Enrolling
Updated: 4/5/2018
Cairo University
mi
from
Giza,
Click here to add this to my saved trials